Athletigen Company
Delivering world-class DNA analysis techology to optimize performance in elite athletes and develop precision products
Industry:
P4 Medicine
Last Funding Type:
Seed
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Total Funding:
$1.6M
Investors Number:
3
Headquarters:
Canada
Technology:
P4 Medicine
Investor Type:
For Profit
Acquisitions Number:
1
Founded Date:
2014-03-01
Employee Number:
11-50